Controversies in the Management of Central Nervous System Coccidioidomycosis.
Coccidioides
Valley Fever
coccidioidomycosis
intracranial pressure
meningitis
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
10 09 2022
10 09 2022
Historique:
received:
11
04
2022
pubmed:
20
6
2022
medline:
14
9
2022
entrez:
19
6
2022
Statut:
ppublish
Résumé
Central nervous system infection with Coccidioides spp. is fatal if untreated and complications occur even when therapy is directed by experienced clinicians. We convened a panel of clinicians experienced in the management of coccidioidal meningitis to summarize current controversies and provide consensus for the management of this difficult infection.
Identifiants
pubmed: 35717645
pii: 6611484
doi: 10.1093/cid/ciac478
doi:
Substances chimiques
Antifungal Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
555-559Informations de copyright
The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Déclaration de conflit d'intérêts
Potential conflicts of interest. G. R. T.: Grants and consulting: Astellas, Cidara, Mayne, F2G, Scynexis; Grants: Merck; DSMB: Pfizer. D. A. S.: Grants: Valley Fever Solutions (support studies on nikkomycin). Research contracts for animal model and in vitro studies (no clinical studies). All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.